Search Results

There are 13934 results for: content related to: Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

  1. You have free access to this content
    Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions

    HIV Medicine

    Volume 14, Issue 7, August 2013, Pages: 430–436, M Winnock, F Bani-Sadr, E Pambrun, M-A Loko, P Carrieri, D Neau, P Morlat, B Marchou, F Dabis, D Salmon and for the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group

    Version of Record online : 5 MAR 2013, DOI: 10.1111/hiv.12023

  2. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  3. You have free access to this content
    European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients

    HIV Medicine

    Volume 15, Issue 7, August 2014, Pages: 425–430, M Guzmán-Fulgencio, N Rallón, J Berenguer, A Fernández-Rodríguez, V Soriano, P Miralles, MA Jiménez-Sousa, C Restrepo, JC López, M García-Álvarez, T Aldámiz, JM Benito and S Resino

    Version of Record online : 24 FEB 2014, DOI: 10.1111/hiv.12126

  4. You have full text access to this OnlineOpen article
    Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

    HIV Medicine

    Volume 14, Issue 6, July 2013, Pages: 370–378, D Grint, L Peters, J Reekie, V Soriano, O Kirk, B Knysz, O Suetnov, A Lazzarin, B Ledergerber, JK Rockstroh, A Mocroft and for EuroSIDA in EuroCoord (European Coordinating Committee for the Integration of Ongoing Coordination Actions Related to Clinical and Epidemiological HIV Research)

    Version of Record online : 27 MAR 2013, DOI: 10.1111/hiv.12033

  5. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy

    HIV Medicine

    L Milazzo, A Lai, E Calvi, P Ronzi, V Micheli, F Binda, AL Ridolfo, C Gervasoni, M Galli, S Antinori and S Sollima

    Version of Record online : 1 AUG 2016, DOI: 10.1111/hiv.12429

  6. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1198–1206, Maryam Alavi, Jesse D. Raffa, Gregory D. Deans, Calvin Lai, Mel Krajden, Gregory J. Dore, Mark W. Tyndall and Jason Grebely

    Version of Record online : 20 NOV 2013, DOI: 10.1111/liv.12370

  7. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response

    Liver International

    Volume 33, Issue 7, August 2013, Pages: 999–1007, Samali Lubega, Uchenna Agbim, Miranda Surjadi, Megan Mahoney and Mandana Khalili

    Version of Record online : 19 MAR 2013, DOI: 10.1111/liv.12150

  8. Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake

    HIV Medicine

    Volume 16, Issue 10, November 2015, Pages: 599–607, V Schaerer, S Haubitz, H Kovari, B Ledergerber, J Ambrosioni, M Cavassini, M Stoeckle, P Schmid, L Decosterd, M Aouri, J Böni, HF Günthard, H Furrer, KJ Metzner, J Fehr, A Rauch and theSwiss HIV Cohort Study

    Version of Record online : 2 JUL 2015, DOI: 10.1111/hiv.12269

  9. High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance

    HIV Medicine

    Volume 15, Issue 10, November 2014, Pages: 615–620, L Peters, A Mocroft, V Soriano, JK Rockstroh, N Kirkby, P Reiss, C Katlama, N Zakharova, R Flisiak, JD Lundgren and for EuroSIDA in EuroCoord

    Version of Record online : 11 MAY 2014, DOI: 10.1111/hiv.12160

  10. You have free access to this content
    Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1452–1463, George V. Papatheodoridis, Emmanuel Tsochatzis, Svenja Hardtke and Heiner Wedemeyer

    Version of Record online : 16 MAY 2014, DOI: 10.1111/liv.12565

  11. You have free access to this content
    Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 355–361, P Ingiliz, I Krznaric, H-J Stellbrink, G Knecht, T Lutz, C Noah, H Stocker, M Obermeier, S Dupke, C Boesecke, JK Rockstroh, A Baumgarten and C Hoffmann

    Version of Record online : 24 FEB 2014, DOI: 10.1111/hiv.12127

  12. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]

    HIV Medicine

    L Michel, C Lions, M Winnock, J-P Lang, M-A Loko, E Rosenthal, B Marchou, M-A Valantin, P Morlat, P Roux, P Sogni, B Spire, I Poizot-Martin, K Lacombe, C Lascoux-Combe, C Duvivier, D Neau, F Dabis, D Salmon-Ceron, MP Carrieri and for the ANRS HEPAVIH CO13 study group

    Version of Record online : 17 MAY 2016, DOI: 10.1111/hiv.12382

  13. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients

    HIV Medicine

    Volume 15, Issue 10, November 2014, Pages: 625–630, DL Braun, A Rauch, N Durisch, N Eberhard, A Anagnostopoulos, B Ledergerber, KJ Metzner, J Böni, R Weber and J Fehr

    Version of Record online : 3 JUN 2014, DOI: 10.1111/hiv.12166

  14. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms

    HIV Medicine

    Volume 15, Issue 10, November 2014, Pages: 621–624, CL Cooper and MB Klein

    Version of Record online : 6 MAY 2014, DOI: 10.1111/hiv.12161

  15. You have free access to this content
    HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality

    HIV Medicine

    Volume 14, Issue 1, January 2013, Pages: 10–20, MB Klein, KC Rollet, S Saeed, J Cox, M Potter, J Cohen, B Conway, C Cooper, P Côté, J Gill, D Haase, S Haider, M Hull, E Moodie, J Montaner, N Pick, A Rachlis, D Rouleau, R Sandre, M Tyndall, S Walmsley and Canadian HIV-HCV Cohort Investigators

    Version of Record online : 28 MAY 2012, DOI: 10.1111/j.1468-1293.2012.01028.x

  16. Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study

    Journal of Viral Hepatitis

    Volume 22, Issue 11, November 2015, Pages: 914–925, M. Alavi, M. Micallef, E. Fortier, A. J. Dunlop, A. C. Balcomb, C. A. Day, C. Treloar, N. Bath, P. S. Haber, G. J. Dore, J. Grebely and on behalf of the ETHOS Study Group

    Version of Record online : 21 MAY 2015, DOI: 10.1111/jvh.12415

  17. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients

    HIV Medicine

    Volume 16, Issue 4, April 2015, Pages: 211–218, FA Gonzalez, E Van den Eynde, S Perez-Hoyos, J Navarro, A Curran, J Burgos, V Falcó, I Ocaña, E Ribera and M Crespo

    Version of Record online : 18 SEP 2014, DOI: 10.1111/hiv.12197

  18. You have full text access to this OnlineOpen article
    HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients

    HIV Medicine

    Volume 16, Issue 1, January 2015, Pages: 24–31, C Cooper, KC Rollet-Kurhajec, J Young, C Vasquez, M Tyndall, J Gill, N Pick, S Walmsley, MB Klein and the Canadian Co-infection Cohort Study Investigators

    Version of Record online : 18 MAY 2014, DOI: 10.1111/hiv.12168

  19. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011

    Journal of Viral Hepatitis

    Volume 21, Issue 3, March 2014, Pages: 198–207, J. Iversen, J. Grebely, L. Topp, H. Wand, G. Dore and L. Maher

    Version of Record online : 1 JUL 2013, DOI: 10.1111/jvh.12129

  20. Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults

    Journal of Viral Hepatitis

    Volume 20, Issue 10, October 2013, Pages: 708–714, E. Y. Chen, C. S. North, O. Fatunde, I. Bernstein, S. Salari, B. Day and M. K. Jain

    Version of Record online : 1 APR 2013, DOI: 10.1111/jvh.12095